You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 750 A phase 1 trial of CUE-102, a novel WT1-pHLA-IL2-Fc fusion protein in HLA-A*0201 positive patients with WT1-positive recurrent/metastatic cancers

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
750 A phase 1 trial of CUE-102, a novel WT1-pHLA-IL2-Fc fusion protein in HLA-A*0201 positive patients with WT1-positive recurrent/metastatic cancers

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023248018
Dec 20234406
Jan 20245705
Feb 20246604
Mar 20248203
Apr 2024154011
May 20249603
Jun 20248203
Jul 20249404
Aug 20248402
Sep 20245405
Oct 202413009
Nov 202410007
Dec 20249608
Jan 202573012
Feb 20253609
Mar 2025009
Apr 2025003
May 2025008
Jun 2025004
Total14960133